|This Slide: #27 of 100|
Slide #27. Quest Diagnostics — Solstas Lab Partners
Quest Diagnostics (NYSE:DGX)
Solstas Lab Partners
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive agreement under which Quest will acquire Solstas Lab Partners Group and its subsidiaries (Solstas) for a total transaction value of approximately $570 million. Solstas is a portfolio company of Welsh, Carson, Anderson and Stowe, a private-equity firm specializing in information/business services and healthcare businesses.
Quest Diagnostics is a provider of diagnostic information services. Co. is comprised of two businesses: Diagnostic Information Services and Diagnostic Solutions. Co.'s Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers and accountable care organizations. Co.'s Diagnostic Solutions group includes its risk assessment services business, which provides solutions for insurers, and its healthcare information technology businesses, which provides solutions for healthcare providers.
Quest Diagnostics SEC Filing Email Alerts Service
Open the DGX Page at The Online Investor »
Buy (2.58 out of 4)
(ranked lower than approx. 79% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite